news Microtitration assay developed to detect Ebola virus in vitro 24 May 2021 | By Victoria Rees (Drug Target Review) Researchers have successfully created an unbiased, high-throughput microtitration assay for the quantification of Ebola virus in cell lines.
news Computational modelling reveals SARS-CoV-2 mutation ‘hotspots’ 20 May 2021 | By Victoria Rees (Drug Target Review) A new modelling method could be used as a surveillance tool to monitor emerging infectious SARS-CoV-2 variants, scientists say.
news Genomic analysis reveals cellular cause of type 1 diabetes 20 May 2021 | By Victoria Rees (Drug Target Review) Combining two genomic methodologies, researchers have shown that pancreatic exocrine cells are implicated in type 1 diabetes.
news New mouse model could be used to develop better HIV treatments 17 May 2021 | By Victoria Rees (Drug Target Review) A new pre-clinical mouse model could enable the study of HIV infection and the testing of cell therapies against the virus.
whitepaper Catalogue: Cytokines and growth factors from Sino Biological 13 May 2021 | By Sino Biological Inc. Sino Biological has developed 1,000+ cytokines and receptors, including growth factors, cytokines, chemokines, interferons, interleukins, etc.
whitepaper ebook: Accelerate vaccine development 13 May 2021 | By Molecular Devices Our comprehensive portfolio suite is designed to optimize your productivity to get safe and efficacious vaccines and therapeutics to market faster.
whitepaper Brochure: Diabetes Solutions 12 May 2021 | By PerkinElmer Solutions to aid understanding of cellular and molecular pathways in diabetes and translate these findings into prevention and treatment strategies.
whitepaper Case study: Parkinson’s disease modelling for drug discovery 11 May 2021 | By Ncardia The development of a Parkinson’s disease model, using hiPSC-derived neural cells, to assess alpha-synuclein pre-formed fibril-induced toxicity.
webinar Cellular Thermal Shift Assays – bringing relevant target engagement to your drug discovery workflow 11 May 2021 | By PerkinElmer Get the Big Picture and listen to Pharma thought leaders how they view CETSA® and its impact on their Drug Discovery.
news Epithelial cells found to communicate in two distinct ways 10 May 2021 | By Victoria Rees (Drug Target Review) Epithelial cell communication depends on the side of the cell, which could have implications for understanding how cancer spreads.
news Computational epitope map of SARS-CoV-2 Spike protein developed 7 May 2021 | By Victoria Rees (Drug Target Review) Researchers have produced a computational simulation of the SARS-CoV-2 Spike protein, finding spots that glycans do not cover.
news Lab of the Future to be 50 percent virtual by 2030, survey indicates 6 May 2021 | By Victoria Rees (Drug Target Review) Findings from a survey have shown 72 percent of respondents in the life sciences industry think the Lab of the Future will embrace virtual working.
news Genetic profile of skeleton osteocytes mapped for first time 6 May 2021 | By Victoria Rees (Drug Target Review) Researchers have revealed which genes are switched on or off in osteocytes, a bone cell found in the skeleton.
news Antibodies cover entirety of SARS-CoV-2 Spike protein, study shows 5 May 2021 | By Victoria Rees (Drug Target Review) Researchers have found that over 80 percent of antibodies target sections of the SARS-CoV-2 Spike protein other than the RBD.
news New label-free imaging method created to visualise brain samples 5 May 2021 | By Victoria Rees (Drug Target Review) A novel sensitive label-free imaging method has been developed to visualise brain samples using an FxClear-based tissue clearing technique.
